VEGFB and systemic lupus erythematosus: As systemic lupus erythematosus (SLE) is a severe autoimmune inflammatory disease and abnormal activation of CD4+ T cells plays predominant roles in the pathogenesis of SLE, we detected the expression of VEGFB and FLT1 in CD4+ T cells from patients with SLE.